Price Alert

Climb Bio Inc. (CLYM)

NASDAQ: CLYM · Real-Time Price · USD

2.10

-0.09 (-4.11%)

At close: Sep 25, 2025, 3:59 PM

2.12

0.95%

After-hours: Sep 25, 2025, 04:54 PM EDT

-4.11% (1D)

Bid	2.04
Market Cap	142.3M
Revenue (ttm)	n/a
Net Income (ttm)	-46.76M
EPS (ttm)	-0.02
PE Ratio (ttm)	-105
Forward PE	-3.04
Analyst	Buy
Dividends	n/a

Ask	2.14
Volume	335,550
Avg. Volume (20D)	542,452
Open	2.15
Previous Close	2.19
Day's Range	2.08 - 2.15
52-Week Range	1.05 - 5.86
Beta	-0.04
Ex-Dividend Date	n/a

About CLYM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CLYM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CLYM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+12.1%

Climb Bio shares are trading higher after Oppenhei... Unlock content with Pro Subscription

10 months ago

+7.12%

Climb Bio shares are trading higher. The company announced it appointed a new chair to its board of directors.

News

2 weeks ago · zacks.com

Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year?

Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

3 weeks ago · zacks.com

Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, Climb Bio, Inc. (CLYM) could be a good stock pick from a technical perspective. CLYM recently experienced a "golden cross" event, which saw its 50-day simple...

1 month ago · zacks.com

Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?

Here is how Climb Bio, Inc. (CLYM) and Cencora (COR) have performed compared to their sector so far this year.